The New York Proton Center is a state-of-the-art facility established as a partnership between Memorial Sloan Kettering, Montefiore Health System, and Mount Sinai Health System. Opened in 2019, the new center is one of only 30 in the country — and the first in New York State — to offer this advanced treatment for people with cancer.
Proton therapy is a highly targeted form of radiation therapy. It destroys tumors using charged particles called protons. These particles are delivered directly to cancerous cells. The precise nature of proton therapy lowers the impact to normal tissue surrounding a tumor and reduces the risk of treatment-related side effects. Because of its accuracy, proton therapy can also be used in complex cases, for challenging tumors or those located near vital organs, and for pediatric cancers.
The New York Proton Center is located at 225 East 126th Street in the East Harlem neighborhood of Manhattan. Patients can receive treatment at the facility through one of the three participating institutions, although its services are available for anyone with a referral. The New York Proton Center is poised to be one of the busiest proton centers in the country, as well as a vital resource for those in the New York metro region.
“This facility represents an unprecedented commitment to the future of cancer treatment,” says Simon Powell, Chair of the Department of Radiation Oncology at MSK. “New York will continue to lead in the struggle against cancer by offering groundbreaking treatment for many of our most vulnerable patients.”
Read more about proton therapy.
Read more about the New York Proton Center.